Hoth Expands Study of New Gel for EGFR Inhibitor Skin Toxicities
EGFR inhibitors are changing the way that many types of cancers are treated, but these drugs can cause adverse skin reactions, and Hoth Therapeutics, Inc. is hoping to show that their gel offers a potential solution.